- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 38/22 - Hormones
Patent holdings for IPC class A61K 38/22
Total number of patents in this class: 2696
10-year publication summary
|
222
|
209
|
194
|
198
|
161
|
169
|
156
|
133
|
144
|
130
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Mondobiotech Laboratories AG | 311 |
82 |
| Novo Nordisk A/S | 2273 |
49 |
| Mayo Foundation for Medical Education and Research | 3280 |
37 |
| Eli Lilly and Company | 3880 |
34 |
| Hanmi Pharm. Co., Ltd. | 574 |
33 |
| MannKind Corporation | 521 |
32 |
| BioMarin Pharmaceutical Inc. | 375 |
28 |
| Rani Therapeutics, LLC | 200 |
28 |
| Ascendis Pharma Growth Disorders A/S | 57 |
28 |
| Zealand Pharma A/S | 259 |
27 |
| The Regents of the University of California | 20211 |
26 |
| The Board of Trustees of the Leland Stanford Junior University | 6507 |
26 |
| Adocia | 143 |
25 |
| Transdermal Biotechnology, Inc. | 76 |
24 |
| Janssen Pharmaceutica N.V. | 3352 |
22 |
| Sanofi | 4115 |
21 |
| University of Florida Research Foundation, Inc. | 4068 |
18 |
| University of Miyazaki | 136 |
18 |
| Duke University | 3101 |
17 |
| Igisu Co., Ltd | 22 |
17 |
| Other owners | 2104 |